GlassScriptPhysician profile
Chloe Braamse
NPI 1790413367
$675.92
in general payments reported to CMS, 2019-2025
16 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $166 · 2024: $171 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $205.66 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $73.34 | 2023-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $69.43 | 2023-2025 | |
| Inspire Medical Systems, INC. | $47.44 | 2024 | Inspire |
| Exact Sciences Corporation | $46.97 | 2023 | Cologuard Collection Kit |
| Organon LLC | $36.38 | 2024-2025 | Nexplanon |
| Lundbeck LLC | $29.78 | 2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $27.89 | 2024 | |
| Lucid Diagnostics INC. | $24.21 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $20.61 | 2025 | Austedo Xr |
| Hologic Sales and Service, LLC | $18.82 | 2025 | Aptima |
| Merck Sharp & Dohme LLC | $17.33 | 2025 | Capvaxive, Gardasil 9 |
| Philips North America LLC | $15.36 | 2025 | Diagnostic Ecg Service |
| Pfizer INC. | $14.80 | 2024 | |
| Idorsia Pharmaceuticals US INC | $14.41 | 2023 | Quviviq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.49 | 2024 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Braamse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.